Clinical Trial Update: Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing two doses of Estrogel to placebo in postmenopausal symptoms, assessing vasomotor symptoms and vulvar/vaginal atrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Symptoms
• Vulvar and Vaginal Atrophy

Drugs mentioned

• ESTROGEL (Estradiol)

Snippet

Sponsor: ASCEND Therapeutics | Conditions: Postmenopausal Symptoms | Phase 4 | Status: COMPLETED